| P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells G Navarro, RR Sawant, S Biswas, S Essex, C Tros de Ilarduya, ... Nanomedicine 7 (1), 65-78, 2012 | 179 | 2012 |
| Phospholipid–polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery G Navarro, RR Sawant, S Essex, C Tros de ILarduya, VP Torchilin Drug Delivery and Translational Research 1, 25-33, 2011 | 98 | 2011 |
| Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors S Essex, G Navarro, P Sabhachandani, A Chordia, M Trivedi, ... Gene therapy 22 (3), 257-266, 2015 | 75 | 2015 |
| Phospholipid-modified polyethylenimine-based nanopreparations for siRNA–mediated gene silencing: Implications for transfection and the role of lipid components G Navarro, S Essex, RR Sawant, S Biswas, D Nagesha, S Sridhar, ... Nanomedicine: Nanotechnology, Biology and Medicine 10 (2), 411-419, 2014 | 50 | 2014 |
| The “non-viral” approach for siRNA delivery in cancer treatment: a special focus on micelles and liposomes G Navarro, S Essex, VP Torchilin DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of …, 2013 | 8 | 2013 |
| Nanomedicine: Nanotechnology G Navarro, S Essex, RR Sawant, S Biswas, D Nagesha, S Sridhar, ... Biology and Medicine, 2013 | 5 | 2013 |
| Tros de Ilarduya C, Torchilin VPP-glycoprotein silencing with siRNA delivered by DOPE-modified PEIover comes doxorubicin resistance in breast cancer cells G Navarro, RR Sawant, S Biswas, S Essex Nano medicine 7, 65-78, 2012 | 4 | 2012 |
| A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization Using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM) AT Karl, S Essex, J Wisnowski, H Rushing JoVE (Journal of Visualized Experiments), e65200, 2023 | 3 | 2023 |
| Liposomal formulations for focal and targeted drug delivery in cancer and other diseases S Essex, V Torchilin Focal Controlled Drug Delivery, 93-116, 2013 | 2 | 2013 |
| Compositions and methods for delivery of nucleic acids J Rychak, J Yewle, S Essex, CAM Nicholas, P Iovine, JR Hughes, ... US Patent App. 18/249,871, 2024 | | 2024 |
| A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM) A Karl, S Essex, J Wisnowski, H Rushing Journal of Visual Experiments, 2023 | | 2023 |
| Compositions and methods for delivery of nucleic acids J RYCHAK, J YEWLE, S ESSEX, CAM Nicholas, PM IOVINE, ... | | 2022 |
| Preclinical Evaluation of Combined Adeno-Associated Virus and Nanoparticle Delivery of piggyBac (R) Transposon System for Durable Transgene Expression in the Growing Neonatal … J Jiang, B Kok, X Liu, V Pham, D Ebeid, M Dhanani, S Essex, J Yewle, ... MOLECULAR THERAPY 29 (4), 15-15, 2021 | | 2021 |
| Invivofectamine (R) Reagents for In Vivo mRNA Delivery for Research and Therapeutic Use S Essex MOLECULAR THERAPY 26 (5), 285-286, 2018 | | 2018 |
| Invivofectamine (TM) Rx Reagent: Novel Lipid Nanoparticle (LNP) for Therapeutic In Vivo mRNA Delivery to the Liver, Lung and Spleen for Gene Editing Application S Essex, S Mishra, N Andronikou, XJ du Jeu, D Mollerat MOLECULAR THERAPY 25 (5), 326-326, 2017 | | 2017 |
| Novel Phospholipid-modified-polyethylenimine (PLPEI)-based-Nanocarriers for siRNA Delivery S Essex Northeastern University, 2013 | | 2013 |
| Micelle-like nanoparticles as “two-in-one” platform for targeted delivery of siRNA/drug combinations in cancer therapy G Navarro, RR Sawant, S Biswas, S Essex, VP Torchilin | | |
| Rothen-Rutishauser B Roy S Rzigalinski B Sahlgren C Salt A C Bechara, C Berry, M Biggs, S Biswas, M Bitsche, D Boraschi, G Bothun, ... | | |
Vladimir TorchilinUniversity Professor, Northeastern UniversityGeverifieerd e-mailadres voor neu.edu
